Your browser doesn't support javascript.
loading
SARS-COV-2 vaccine: first-month results of a six-month follow-up study.
Mete, Burak; Tanir, Ferdi; Demirhindi, Hakan; Kara, Ertan; Kibar, Filiz; Çetiner, Salih; Candevir, Aslihan; Dal, Rabia.
Afiliação
  • Mete B; Department of Public Health, Faculty of Medicine, Çukurova University, Adana, Turkey.
  • Tanir F; Department of Public Health, Faculty of Medicine, Çukurova University, Adana, Turkey.
  • Demirhindi H; Department of Public Health, Faculty of Medicine, Çukurova University, Adana, Turkey.
  • Kara E; Department of Public Health, Faculty of Medicine, Çukurova University, Adana, Turkey.
  • Kibar F; Department of Medical Microbiology and Çukurova University Balcali Hospital Central Laboratory, Faculty of Medicine, Çukurova University, Adana, Turkey.
  • Çetiner S; Department of Immunology and Çukurova University Balcali Hospital Central Laboratory, Faculty of Medicine, ÇukurovaUniversity, Adana, Turkey.
  • Candevir A; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Çukurova University, Adana, Turkey.
  • Dal R; Department of Public Health, Faculty of Medicine, Çukurova University, Adana, Turkey.
Turk J Med Sci ; 52(1): 21-31, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34688238

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Turk J Med Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Turk J Med Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia